SkepSkep
All episodes
CNBC's "Fast Money" — Would You Rather?: Goldman Sachs or The Mag7… And Structure Therapeutics CEO  1/15/26
Scout ratingSCOUT· 60%43m·2026-01-15·Money

Would You Rather?: Goldman Sachs or The Mag7… And Structure Therapeutics CEO 1/15/26

CNBC's "Fast Money"

Goldman Sachs surging to fresh records as earnings top estimates, while some Mag7 stocks continue to struggle against the broader market. So will the big bank keep bumping, or can the big tech trouble make a turnaround? Plus the weight loss drug wars are heating up, with focus turning to the GLP-1 pill. The latest…

Listen now
Buzzmeter · cross-platform
Scout rating
60%
SCOUT

Scout bees are checking it out — divided opinions, the swarm hasn't committed.

Hive Vote · Skep listeners
New on SkepAwaiting the hive's first votes

Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.

Rate this episode

Add your vote to the Hive — listeners rate every episode after they finish.

Rate this episode
Recent reviews
  • No reviews yet — be the first.

One great episode in your inbox, daily — free.

One email a day, unsubscribe anytime. No spam, ever.